• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Upcoming dvm360 Conferences
Resources
CBD in Pets
CE Requirements by State
Contests
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
Veterinary Heroes
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Practical Matters: Urine cortisol:creatinine ratio-the most useful normal test around

July 1, 2006
Nyssa J. Reine, DVM, DACVIM (small animal internal medicine)

Definitively diagnosing canine hyperadrenocorticism (Cushing's disease) can be exceptionally difficult because nonadrenal illness can affect the test results. However, I think that the urine cortisol:creatinine ratio (UC:Cr) serves an invaluable role in ruling out canine Cushing's disease since a dog with a normal UC:Cr almost assuredly does not have Cushing's disease.

Definitively diagnosing canine hyperadrenocorticism (Cushing's disease) can be exceptionally difficult because nonadrenal illness can affect the test results. However, I think that the urine cortisol:creatinine ratio (UC:Cr) serves an invaluable role in ruling out canine Cushing's disease since a dog with a normal UC:Cr almost assuredly does not have Cushing's disease.

Dogs with hypercortisolemia have increased excretion of cortisol in their urine. This excretion can be compared to creatinine excretion, which should be fairly constant in dogs with normal renal function. False-positive elevation of the UC:Cr (i.e. elevation not related to Cushing's disease) can occur in patients with gastrointestinal, renal, lower urinary tract, liver, neurologic, or immune-mediated diseases or congestive heart failure.1 Although the UC:Cr is more frequently elevated than it is normal, when it is normal, you know that your patient does not have Cushing's disease and that you need to look for another possible cause for the patient's clinical signs.

It is preferable to perform a UC:Cr on a free-catch sample collected at home in the morning because a patient's stress from visiting the hospital or undergoing a cystocentesis can alter the UC:Cr.2 With this in mind, I will typically have my clients wait a few days after our appointment to collect the sample for submission.

With the recent changes in availability and pricing of synthetic corticotropin (cosyntropin), which is used in the ACTH response test, keep in mind that the UC:Cr also can be used as a monitoring tool. Although several studies have documented that it is not ideal to use the UC:Cr as a monitoring tool during the loading phase of mitotane treatment, it can be used safely during the maintenance phase because of the low risk of hypoadrenocorticism occurring compared with the risk during the loading phase. The problem with using the UC:Cr to monitor patients during the loading phase is its inability to differentiate between well-controlled and overdosed patients. This distinction is important as well-controlled patients would be switched to maintenance treatment but overdosed patients would require close monitoring and potential treatment for hypoadrenocorticism.

Advertisement

A diagnosis of Cushing's disease depends on a conglomeration of clinical acumen, biochemical abnormalities, and the results of provocative testing and of a physical examination. The process of confirming the diagnosis can be costly. Performing a UC:Cr early in the protocol can save clients money and provide you with an excellent diagnostic tool.

REFERENCES

1. Smiley LE, Peterson ME. Evaluation of a urine cortisol:creatinine ratio as a screening test for hyperadrenocorticism in dogs. J Vet Intern Med 1993;7:163-168.

2. Van Vonderen IK, Kooistra HS, Rijnberk A. Influence of veterinary care on the urinary corticoid:creatinine ratio in dogs. J Vet Intern Med 1998;12:431-435.

Nyssa J. Reine, DVM, DACVIM

(small animal internal medicine)

Department of Medicine

The Animal Medical Center

510 E. 62nd St.

New York, NY 10021

Nyssa J. Reine, DVM, DACVIM (small animal internal medicine)

Related Content:

Urology/Nephrology
Top dvm360 articles of 2022: #16
Top dvm360 articles of 2022: #16
Cummings School of Veterinary Medicine recruiting patients for UTI clinical trial
Cummings School of Veterinary Medicine recruiting patients for UTI clinical trial
High creatinine levels, low urine output lead to leptospirosis diagnosis
High creatinine levels, low urine output lead to leptospirosis diagnosis

Advertisement

Latest News

The Vets appoints Dr Zach Mills to VP of Medical Performance

Communicating the importance of genetic screening

Purina announces its 2023 Pet Care Innovation Prize winners

AmeriVet Veterinary Partners deemed a 2022 Business of the Year

View More Latest News
Advertisement